Targeted cancer drugs: What’s on the market? What’s in the pipeline?

 

While immunotherapies get most of the headlines, targeted cancer treatments have revolutionized oncology in recent years as well, changing the lives of some patients by homing in on genetically defined tumors.

In this webinar, we’ll take a look at some of the most important recently approved targeted therapies and examine the pipeline of medicines yet to come, looking at the underlying science, the clinical data, and the often surprising costs associated with these drugs.

 

Sponsored By: